Mogamulizumab-induced interface dermatitis drug rash treated successfully with methotrexate and extracorporeal photopheresis in a patient with Sézary syndrome

Saved in:
Bibliographic Details
Published inJAAD Case Reports Vol. 9; pp. 24 - 27
Main Authors Breen, Ilana D., Brumfiel, Caitlin M., Patel, Meera H., Rosenthal, Allison C., Rule, William G., DiCaudo, David J., Craig, Fiona E., Pittelkow, Mark R., Mangold, Aaron R.
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.03.2021
Elsevier
Subjects
Case Report
Cutaneous T-cell lymphoma
extracorporeal photopheresis
interface dermatitis
methotrexate
mogamulizumab
Sézary
SS
mogamulizumab
extracorporeal photopheresis
ECP
methotrexate
MF
Sézary
interface dermatitis
CCR4
Cutaneous T-cell lymphoma
SS, Sézary syndrome
CCR4, C-C chemokine receptor 4
ECP, extracorporeal photopheresis
MF, mycosis fungoides
Online AccessGet full text

Cover

More Information
ISSN:2352-5126
2352-5126
DOI:10.1016/j.jdcr.2020.12.035